FDA ENDOSSEOUS IMPLANT GUIDANCE DOCUMENTS WILL BE CONSOLIDATED, AGENCY SAYS; DENTAL PANEL MEMBERS RECOMMEND ONE GUIDANCE EACH FOR 510(K)s AND PMAs
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to consolidate the approximately dozen guidances it has developed on endosseous implants as pan of its effort to finalize a classification scheme for the dental devices, the agency indicated at a Dec. 7 meeting of its Dental Products Panel in Washington, D.C.